7Baggers
 PLX: Protalix Seeks Re-Examination of CHMP Opinion  Yahoo Finance Mon, 17 Nov 2025 10:27:00 GMT
 Protalix BioTherapeutics Reports Strong Revenue Growth in 2025  TipRanks Fri, 14 Nov 2025 04:29:24 GMT
 Protalix: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 13 Nov 2025 12:55:41 GMT
 Protalix BioTherapeutics Sees Slower Growth As Revenue Slips  Finimize Thu, 13 Nov 2025 12:35:15 GMT
 Protalix (PLX) Posts Q3 Revenue Slightly Below Expectations  GuruFocus Thu, 13 Nov 2025 12:34:11 GMT
 Preview: Protalix BioTherapeutics's Earnings  Benzinga Wed, 12 Nov 2025 17:02:12 GMT
 published on: 2025-11-10 00:19:34  newser.com Mon, 10 Nov 2025 06:19:34 GMT
 how protalix biotherapeutics inc. stock reacts to job market data  newser.com Thu, 06 Nov 2025 08:55:41 GMT
 protalix and chiesi seek ema re-examination of elfabrio dosing opinion  Proactive financial news Tue, 04 Nov 2025 13:57:00 GMT
 chiesi and protalix seek review of ema’s negative opinion on elfabrio  Investing.com Australia Tue, 04 Nov 2025 13:24:37 GMT
 protalix seeks ema re-examination for elfabrio dosing  The Globe and Mail Tue, 04 Nov 2025 08:00:00 GMT

Protalix BioTherapeutics, Inc
(NYSE MKT:PLX) 

PLX stock logo

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company o...

Founded: 1993
Full Time Employees: 196
CEO: Dror Bashan  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends